**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 6332-56-5 |2-Hydroxy-3-nitropyridine | 98 | 228-709-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 36/37/38 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Limited evidence of
a carcinogenic effect.The toxicological properties of this material
have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary
edema.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion. Runoff from fire control or dilution
water may cause pollution.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Wash clothing before reuse. Avoid breathing dust.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 6332-56-5:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: yellow to brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 212 deg C (dec)
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 212 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H4N2O3
Molecular Weight: 140.10
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
High temperatures, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide, cyanide fumes.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 6332-56-5: UU7718000
LD50/LC50:
Not available.
Carcinogenicity:
2-Hydroxy-3-nitropyridine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 6332-56-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6332-56-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6332-56-5 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/04/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Sulfamic acid
| 5329-14-6 |
|
3-Chlorocinnamic Acid, Predominantly Trans 99+%
| 1866-38-2 |
|
4-(Bromomethyl)-7-Methoxycoumarin 99%
| 35231-44-8 |
|
2-Hydroxy-3-nitropyridine, 98%
| 6332-56-5 |
|
Sulfanilamide
| 63-74-1 |
|
Sulfanilic acid
| 121-57-3 |
|
Nicotine sulfate, 40% aqueous solution
| 65-30-5 |
|
2-Bromobenzaldehyde, 97%
| 6630-33-7 |
|
Bicyclo (3.2.1)Octan-2-One, 90-95%(GC)
| 5019-82-9 |
|
Benzo??b??naphtho??2,3-d??thiophene, 99.5+%
| 243-46-9 |
|
Triethyl Orthoacetate, 99% (GC)
| 78-39-7 |
|
5-Sulfosalicylic acid dihydrate
| 97-05-2 |
|
4-Benzoyloxy-2-Azetidinone, 99%
| 28562-58-5 |
|
Sulfur (Precipitated and Sublimed)
| 7704-34-9 |
|
N-Methyl-Beta-Alaninenitrile, 98%
| 693-02-7 |
|
Trimethyl Orthovalerate
| 13820-09-2 |
|
Ethyl diethoxyphosphinylformate, 98%
| 1474-78-8 |
|
S-Methyl-L-Cysteine, 99+%
| 1187-84-4 |
|
N-Benzoyl-4-Piperidone, 97%
| 24686-78-0 |
|
Succinimide, 99%
| 123-56-8 |
|
Sulfuric acid 90-98%
| 7664-93-9 |
|
Sulfurous Acid
| 7782-99-2 |
|
Silver trifluoromethanesulfonate, 99+%
| 2923-28-6 |
|
Rhodanine-n-acetic acid, 98%
| 5718-83-2 |
|
Tannic Acid
| 1401-55-4 |
|
Diphenic Anhydride, 98%
| 6050-13-1 |
|
4-(Dimethylamino)butyric Acid Hydrochloride, 98%
| 69954-66-1 |
|
(4S,5S)-4,5-Di(aminomethyl)-2,2-dimethyldioxolane, 99+%
| 119322-88-2 |
|
4-Acryloylamidobenzo-18-Crown-6, 98%
| 0-00-1 |
|
2-Thio-6-hydroxypurine hydrate, 98%
| 2487-40-3 |
|
3-Methyl-4-nitrobenzoic acid, 99%
| 3113-71-1 |
|
L-(+)-Tartaric acid
| 87-69-4 |
|
3-Methyl-2-pyrazolin-5-one, 99% (titr.)
| 108-26-9 |
|
2-Nitronaphthalene, tech., 85%
| 581-89-5 |
|
2,6-Dibromopyridine, 98%
| 626-05-1 |
|
5-Methylfurfural, 98+%
| 620-02-0 |
|
Ammonium orthoarsenate trihydrate, 99.999%
| 13477-86-6 |
|
n-Benzylglycine ethyl ester hydrochloride, 98%
| |
|
N-Alpha-Acetyl-L-Lysine-N-Methylamide Monohydrate, 99+%, (TLC)
| 81013-00-5 |
|
(+)-Dimethyl L-Tartrate, 99%
| 608-68-4 |
|
2,5-Dibromotoluene, 99%
| 615-59-8 |
|
2-Aminoperimidine, Hydrobromide Sesquihydrate, 98%
| 40835-96-9 |
|
Nucleic Acid (Pract), 90% (UV-VIS)
| 9008-72-4 |
|
Ethyl 3-Endo-Aminobicyclo[2.2.1]Hept-5-ene -2-Endo-Carboxylate
| 95630-74-3 |
|
Cyclopentanemethanol, 96%
| 3637-61-4 |
|
Tetrahexylammonium Bromide, 99% (Titr.)
| 4328-13-6 |
|
1-(4-Chlorophenyl)-1-cyclohexanecarbonitrile
| |
|
Potassium deuteroxide, 40 wt% solution in d2o, 98+ atom % d
| 24572-01-8 |
|
1-(2-Methoxyphenyl)piperazine, 98+% (GC)
| 35386-24-4 |
|
4-Carboxybenzo-15-Crown-5, 99+%
| 0-00-1 |
|
|